Skip to main content
Top
Published in: Obesity Surgery 8/2016

01-08-2016 | Original Contributions

The Effects of Bariatric Surgery-Induced Weight Loss on Adipose Tissue in Morbidly Obese Women Depends on the Initial Metabolic Status

Authors: Natalia Moreno-Castellanos, Rocío Guzmán-Ruiz, David A. Cano, Ainara Madrazo-Atutxa, Juan R. Peinado, Jose L. Pereira-Cunill, Pedro Pablo García-Luna, Salvador Morales-Conde, Maria Socas-Macias, Rafael Vázquez-Martínez, Alfonso Leal-Cerro, María M. Malagón

Published in: Obesity Surgery | Issue 8/2016

Login to get access

Abstract

Background

Adipose tissue (AT) dysfunction in obesity is commonly linked to insulin resistance and promotes the development of metabolic disease. Bariatric surgery (BS) represents an effective strategy to reduce weight and to improve metabolic health in morbidly obese subjects. However, the mechanisms and pathways that are modified in AT in response to BS are not fully understood, and few information is still available as to whether these may vary depending on the metabolic status of obese subjects.

Methods

Abdominal subcutaneous adipose tissue (SAT) samples were obtained from morbidly obese women (n = 18) before and 13.3 ± 0.37 months after BS. Obese women were stratified into two groups: normoglycemic (NG; Glu < 100 mg/dl, HbA1c <5.7 %) or insulin resistant (IR; Glu 100–126 mg/dl, HbA1c 5.7–6.4 %) (n = 9/group). A multi-comparative proteomic analysis was employed to identify differentially regulated SAT proteins by BS and/or the degree of insulin sensitivity. Serum levels of metabolic, inflammatory, and anti-oxidant markers were also analyzed.

Results

Before surgery, NG and IR subjects exhibited differences in AT proteins related to inflammation, metabolic processes, the cytoskeleton, and mitochondria. BS caused comparable weight reductions and improved glucose homeostasis in both groups. However, BS caused dissimilar changes in metabolic enzymes, inflammatory markers, cytoskeletal components, mitochondrial proteins, and angiogenesis regulators in NG and IR women.

Conclusions

BS evokes significant molecular rearrangements indicative of improved AT function in morbidly obese women at either low or high metabolic risk, though selective adaptive changes in key cellular processes occur depending on the initial individual’s metabolic status.
Appendix
Available only for authorised users
Literature
3.
go back to reference Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.CrossRefPubMed Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.CrossRefPubMed
4.
go back to reference Bluher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013;27(2):163–77.CrossRefPubMed Bluher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013;27(2):163–77.CrossRefPubMed
5.
go back to reference Diaz-Ruiz A, Guzman-Ruiz R, Moreno NR, et al. Proteasome dysfunction associated to oxidative stress and proteotoxicity in adipocytes compromises insulin sensitivity in human obesity. Antioxid Redox Signal. 2015;23(7):597–612.CrossRefPubMedPubMedCentral Diaz-Ruiz A, Guzman-Ruiz R, Moreno NR, et al. Proteasome dysfunction associated to oxidative stress and proteotoxicity in adipocytes compromises insulin sensitivity in human obesity. Antioxid Redox Signal. 2015;23(7):597–612.CrossRefPubMedPubMedCentral
6.
go back to reference Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract. 2013;7(5):e330–41.CrossRefPubMed Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract. 2013;7(5):e330–41.CrossRefPubMed
8.
go back to reference Malkani S. An update on the role of bariatric surgery in diabetes management. Curr Opin Endocrinol Diabetes Obes. 2015;22(2):98–105.CrossRefPubMed Malkani S. An update on the role of bariatric surgery in diabetes management. Curr Opin Endocrinol Diabetes Obes. 2015;22(2):98–105.CrossRefPubMed
9.
go back to reference Yu J, Zhou X, Li L, et al. The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence. Obes Surg. 2015;25(1):143–58.CrossRefPubMed Yu J, Zhou X, Li L, et al. The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence. Obes Surg. 2015;25(1):143–58.CrossRefPubMed
10.
go back to reference Clement K. Bariatric surgery, adipose tissue and gut microbiota. Int J Obes (Lond). 2011;35 Suppl 3:S7–15.CrossRef Clement K. Bariatric surgery, adipose tissue and gut microbiota. Int J Obes (Lond). 2011;35 Suppl 3:S7–15.CrossRef
11.
go back to reference Mendez-Gimenez L, Becerril S, Moncada R, et al. Sleeve gastrectomy reduces hepatic steatosis by improving the coordinated regulation of aquaglyceroporins in adipose tissue and liver in obese rats. Obes Surg. 2015;25(9):1723–34.CrossRefPubMed Mendez-Gimenez L, Becerril S, Moncada R, et al. Sleeve gastrectomy reduces hepatic steatosis by improving the coordinated regulation of aquaglyceroporins in adipose tissue and liver in obese rats. Obes Surg. 2015;25(9):1723–34.CrossRefPubMed
12.
go back to reference Appachi S, Kelly KR, Schauer PR, et al. Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy". Obes Surg. 2011;21(12):1928–36.CrossRefPubMedPubMedCentral Appachi S, Kelly KR, Schauer PR, et al. Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy". Obes Surg. 2011;21(12):1928–36.CrossRefPubMedPubMedCentral
13.
go back to reference Benraouane F, Litwin SE. Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol. 2011;26(6):555–61.CrossRefPubMed Benraouane F, Litwin SE. Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol. 2011;26(6):555–61.CrossRefPubMed
14.
15.
go back to reference Dankel SN, Fadnes DJ, Stavrum AK, et al. Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One. 2010;5(6), e11033.CrossRefPubMedPubMedCentral Dankel SN, Fadnes DJ, Stavrum AK, et al. Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One. 2010;5(6), e11033.CrossRefPubMedPubMedCentral
16.
go back to reference Henegar C, Tordjman J, Achard V, et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008;9(1):R14.CrossRefPubMedPubMedCentral Henegar C, Tordjman J, Achard V, et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008;9(1):R14.CrossRefPubMedPubMedCentral
17.
go back to reference Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54(8):2277–86.CrossRefPubMed Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54(8):2277–86.CrossRefPubMed
18.
go back to reference Moreno-Navarrete JM, Ortega F, Serrano M, et al. CIDEC/FSP27 and PLIN1 gene expression run in parallel to mitochondrial genes in human adipose tissue, both increasing after weight loss. Int J Obes (Lond). 2014;38(6):865–72.CrossRef Moreno-Navarrete JM, Ortega F, Serrano M, et al. CIDEC/FSP27 and PLIN1 gene expression run in parallel to mitochondrial genes in human adipose tissue, both increasing after weight loss. Int J Obes (Lond). 2014;38(6):865–72.CrossRef
19.
go back to reference Eriksson-Hogling D, Andersson DP, Backdahl J, et al. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. Int J Obes (Lond). 2015;39(6):893–8. Eriksson-Hogling D, Andersson DP, Backdahl J, et al. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. Int J Obes (Lond). 2015;39(6):893–8.
20.
go back to reference Cotillard A, Poitou C, Torcivia A, et al. Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab. 2014;99(8):E1466–70.CrossRefPubMed Cotillard A, Poitou C, Torcivia A, et al. Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab. 2014;99(8):E1466–70.CrossRefPubMed
21.
go back to reference Divoux A, Tordjman J, Lacasa D, et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes. 2010;59(11):2817–25.CrossRefPubMedPubMedCentral Divoux A, Tordjman J, Lacasa D, et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes. 2010;59(11):2817–25.CrossRefPubMedPubMedCentral
22.
go back to reference Bluher S, Schwarz P. Metabolically healthy obesity from childhood to adulthood—Does weight status alone matter? Metabolism. 2014;63(9):1084–92.CrossRefPubMed Bluher S, Schwarz P. Metabolically healthy obesity from childhood to adulthood—Does weight status alone matter? Metabolism. 2014;63(9):1084–92.CrossRefPubMed
23.
go back to reference Denis GV, Obin MS. 'Metabolically healthy obesity': origins and implications. Mol Aspects Med. 2013;34(1):59–70.CrossRefPubMed Denis GV, Obin MS. 'Metabolically healthy obesity': origins and implications. Mol Aspects Med. 2013;34(1):59–70.CrossRefPubMed
24.
go back to reference Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35(7):971–81.CrossRef Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35(7):971–81.CrossRef
25.
go back to reference American DA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35 Suppl 1:S64–71.CrossRef American DA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35 Suppl 1:S64–71.CrossRef
26.
go back to reference Martin-Rodriguez JF, Cervera-Barajas A, Madrazo-Atutxa A, et al. Effect of bariatric surgery on microvascular dysfunction associated to metabolic syndrome: a 12-month prospective study. Int J Obes (Lond). 2014;38(11):1410–5.CrossRef Martin-Rodriguez JF, Cervera-Barajas A, Madrazo-Atutxa A, et al. Effect of bariatric surgery on microvascular dysfunction associated to metabolic syndrome: a 12-month prospective study. Int J Obes (Lond). 2014;38(11):1410–5.CrossRef
27.
go back to reference Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta. 2011;1813(7):1269–78.CrossRefPubMed Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta. 2011;1813(7):1269–78.CrossRefPubMed
28.
go back to reference Peinado JR, Quiros PM, Pulido MR, et al. Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing. Mol Cell Proteomics. 2011;10(11):M111 008094.CrossRefPubMedPubMedCentral Peinado JR, Quiros PM, Pulido MR, et al. Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing. Mol Cell Proteomics. 2011;10(11):M111 008094.CrossRefPubMedPubMedCentral
29.
go back to reference Brackley KI, Grantham J. Activities of the chaperonin containing TCP-1 (CCT): implications for cell cycle progression and cytoskeletal organisation. Cell Stress Chaperones. 2009;14(1):23–31.CrossRefPubMed Brackley KI, Grantham J. Activities of the chaperonin containing TCP-1 (CCT): implications for cell cycle progression and cytoskeletal organisation. Cell Stress Chaperones. 2009;14(1):23–31.CrossRefPubMed
31.
go back to reference Klimcakova E, Roussel B, Marquez-Quinones A, et al. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. J Clin Endocrinol Metab. 2011;96(1):E73–82.CrossRefPubMed Klimcakova E, Roussel B, Marquez-Quinones A, et al. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. J Clin Endocrinol Metab. 2011;96(1):E73–82.CrossRefPubMed
32.
go back to reference del Pozo CH, Calvo RM, Vesperinas-Garcia G, et al. Expression profile in omental and subcutaneous adipose tissue from lean and obese subjects. Repression of lipolytic and lipogenic genes. Obes Surg. 2011;21(5):633–43.CrossRefPubMed del Pozo CH, Calvo RM, Vesperinas-Garcia G, et al. Expression profile in omental and subcutaneous adipose tissue from lean and obese subjects. Repression of lipolytic and lipogenic genes. Obes Surg. 2011;21(5):633–43.CrossRefPubMed
33.
go back to reference Dharuri H, 't Hoen PA, van Klinken JB, et al. Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss. Diabetologia. 2014;57(11):2384–92.CrossRefPubMed Dharuri H, 't Hoen PA, van Klinken JB, et al. Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss. Diabetologia. 2014;57(11):2384–92.CrossRefPubMed
34.
go back to reference Reshef L, Olswang Y, Cassuto H, et al. Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem. 2003;278(33):30413–6.CrossRefPubMed Reshef L, Olswang Y, Cassuto H, et al. Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem. 2003;278(33):30413–6.CrossRefPubMed
35.
go back to reference Camastra S, Gastaldelli A, Mari A, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia. 2011;54(8):2093–102.CrossRefPubMed Camastra S, Gastaldelli A, Mari A, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia. 2011;54(8):2093–102.CrossRefPubMed
36.
go back to reference da Silva VR, Moreira EA, Wilhelm-Filho D, et al. Proinflammatory and oxidative stress markers in patients submitted to Roux-en-Y gastric bypass after 1 year of follow-up. Eur J Clin Nutr. 2012;66(8):891–9.CrossRefPubMed da Silva VR, Moreira EA, Wilhelm-Filho D, et al. Proinflammatory and oxidative stress markers in patients submitted to Roux-en-Y gastric bypass after 1 year of follow-up. Eur J Clin Nutr. 2012;66(8):891–9.CrossRefPubMed
37.
go back to reference Joao Cabrera E, Valezi AC, Delfino VD, et al. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-en-Y gastric bypass. Obes Surg. 2010;20(1):42–9.CrossRefPubMed Joao Cabrera E, Valezi AC, Delfino VD, et al. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-en-Y gastric bypass. Obes Surg. 2010;20(1):42–9.CrossRefPubMed
38.
go back to reference Naukkarinen J, Heinonen S, Hakkarainen A, et al. Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia. 2014;57(1):167–76.CrossRefPubMed Naukkarinen J, Heinonen S, Hakkarainen A, et al. Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia. 2014;57(1):167–76.CrossRefPubMed
39.
go back to reference van Beek L, Lips MA, Visser A, et al. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism. 2014;63(4):492–501.CrossRefPubMed van Beek L, Lips MA, Visser A, et al. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism. 2014;63(4):492–501.CrossRefPubMed
40.
go back to reference von der Malsburg K, Muller JM, Bohnert M, et al. Dual role of mitofilin in mitochondrial membrane organization and protein biogenesis. Dev Cell. 2011;21(4):694–707.CrossRefPubMed von der Malsburg K, Muller JM, Bohnert M, et al. Dual role of mitofilin in mitochondrial membrane organization and protein biogenesis. Dev Cell. 2011;21(4):694–707.CrossRefPubMed
41.
go back to reference Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.CrossRefPubMed Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.CrossRefPubMed
Metadata
Title
The Effects of Bariatric Surgery-Induced Weight Loss on Adipose Tissue in Morbidly Obese Women Depends on the Initial Metabolic Status
Authors
Natalia Moreno-Castellanos
Rocío Guzmán-Ruiz
David A. Cano
Ainara Madrazo-Atutxa
Juan R. Peinado
Jose L. Pereira-Cunill
Pedro Pablo García-Luna
Salvador Morales-Conde
Maria Socas-Macias
Rafael Vázquez-Martínez
Alfonso Leal-Cerro
María M. Malagón
Publication date
01-08-2016
Publisher
Springer US
Published in
Obesity Surgery / Issue 8/2016
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1995-x

Other articles of this Issue 8/2016

Obesity Surgery 8/2016 Go to the issue